REORGANIZATION OF THE DIAGNOSTICS BUSINE

Report this content
BIOHIT PLC.  STOCK EXCHANGE RELEASE  14.12.2000 at 12:00        1 (1)
REORGANIZATION OF THE DIAGNOSTICS BUSINESS AREA OF BIOHIT PLC.

It  was decided on December 14, 2000 that Locus genex Oy, a subsidiary
company of Biohit Plc. specializing in the development of diagnostics,
will  be  integrated  more closely with the Biohit  Group  and,  thus,
commence   taking   the   necessary   organizational   measures.   The
extraordinary general meeting of Locus genex Oy decided  on  Dec.  14,
2000  to  place the company in voluntary liquidation after  which  the
company  will be dissolved and all business operations transferred  to
Biohit  Plc.  The  purpose of the reorganization is  to  transfer  the
business  areas of liquid handling, instruments and diagnostics  under
one company and brand name and in this way gain more efficiency in the
marketing  and  distribution of the products. The reorganization  will
also eliminate overlapping activities and cut administrative expenses.
The aim is to complete the reorganization by the end of 2001.

Additional information:  Osmo Suovaniemi, President & CEO
                         Tel: +358-9-773 861, direct: +358-9-773 86
                         250, mobile: +358-50 556 5605, fax: +358-9-
                         773 86 205

                         http://www.biohit.com

Distribution:            Helsinki Exchanges
                         The Financial Supervisory Authority
                         Press


Subscribe